Citigroup’s Arcus Biosciences RCUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.87M Buy
229,298
+19,376
+9% +$158K ﹤0.01% 2090
2025
Q1
$1.65M Buy
209,922
+103,227
+97% +$810K ﹤0.01% 2223
2024
Q4
$1.59M Buy
106,695
+40,739
+62% +$607K ﹤0.01% 2273
2024
Q3
$1.01M Buy
65,956
+18,303
+38% +$280K ﹤0.01% 2554
2024
Q2
$726K Sell
47,653
-268,474
-85% -$4.09M ﹤0.01% 2459
2024
Q1
$5.97M Buy
316,127
+188,896
+148% +$3.57M ﹤0.01% 1150
2023
Q4
$2.43M Sell
127,231
-18,498
-13% -$353K ﹤0.01% 1508
2023
Q3
$2.62M Buy
145,729
+25,083
+21% +$450K ﹤0.01% 1338
2023
Q2
$2.45M Sell
120,646
-231,290
-66% -$4.7M ﹤0.01% 1528
2023
Q1
$6.42M Buy
351,936
+225,255
+178% +$4.11M ﹤0.01% 1005
2022
Q4
$2.62M Sell
126,681
-108,002
-46% -$2.23M ﹤0.01% 1352
2022
Q3
$6.14M Buy
234,683
+56,183
+31% +$1.47M ﹤0.01% 1022
2022
Q2
$4.52M Buy
178,500
+145,896
+447% +$3.7M ﹤0.01% 1164
2022
Q1
$1.03M Sell
32,604
-76,296
-70% -$2.41M ﹤0.01% 2304
2021
Q4
$4.41M Buy
108,900
+46,415
+74% +$1.88M ﹤0.01% 1368
2021
Q3
$2.18M Sell
62,485
-100,784
-62% -$3.51M ﹤0.01% 1854
2021
Q2
$4.48M Buy
163,269
+45,873
+39% +$1.26M ﹤0.01% 1504
2021
Q1
$3.3M Buy
117,396
+93,878
+399% +$2.64M ﹤0.01% 1619
2020
Q4
$611K Buy
23,518
+15,972
+212% +$415K ﹤0.01% 2505
2020
Q3
$129K Sell
7,546
-18,875
-71% -$323K ﹤0.01% 3005
2020
Q2
$654K Buy
26,421
+16,812
+175% +$416K ﹤0.01% 2386
2020
Q1
$133K Buy
9,609
+24
+0.3% +$332 ﹤0.01% 3113
2019
Q4
$97K Buy
9,585
+2,231
+30% +$22.6K ﹤0.01% 3563
2019
Q3
$67K Sell
7,354
-3,689
-33% -$33.6K ﹤0.01% 3638
2019
Q2
$88K Sell
11,043
-232
-2% -$1.85K ﹤0.01% 3716
2019
Q1
$141K Sell
11,275
-120
-1% -$1.5K ﹤0.01% 3360
2018
Q4
$122K Buy
11,395
+5,824
+105% +$62.4K ﹤0.01% 3389
2018
Q3
$78K Buy
5,571
+1,757
+46% +$24.6K ﹤0.01% 3763
2018
Q2
$47K Buy
3,814
+814
+27% +$10K ﹤0.01% 3914
2018
Q1
$46K Buy
+3,000
New +$46K ﹤0.01% 3805